Curriculum Learning for Biological Sequence Prediction: The Case of De Novo Peptide Sequencing
By: Xiang Zhang , Jiaqi Wei , Zijie Qiu and more
Potential Business Impact:
Teaches computers to read protein codes better.
Peptide sequencing-the process of identifying amino acid sequences from mass spectrometry data-is a fundamental task in proteomics. Non-Autoregressive Transformers (NATs) have proven highly effective for this task, outperforming traditional methods. Unlike autoregressive models, which generate tokens sequentially, NATs predict all positions simultaneously, leveraging bidirectional context through unmasked self-attention. However, existing NAT approaches often rely on Connectionist Temporal Classification (CTC) loss, which presents significant optimization challenges due to CTC's complexity and increases the risk of training failures. To address these issues, we propose an improved non-autoregressive peptide sequencing model that incorporates a structured protein sequence curriculum learning strategy. This approach adjusts protein's learning difficulty based on the model's estimated protein generational capabilities through a sampling process, progressively learning peptide generation from simple to complex sequences. Additionally, we introduce a self-refining inference-time module that iteratively enhances predictions using learned NAT token embeddings, improving sequence accuracy at a fine-grained level. Our curriculum learning strategy reduces NAT training failures frequency by more than 90% based on sampled training over various data distributions. Evaluations on nine benchmark species demonstrate that our approach outperforms all previous methods across multiple metrics and species.
Similar Papers
Morphology-Specific Peptide Discovery via Masked Conditional Generative Modeling
Biomolecules
Creates new materials that build themselves into shapes.
Protein as a Second Language for LLMs
Machine Learning (CS)
Helps computers understand how proteins work.
CreoPep: A Universal Deep Learning Framework for Target-Specific Peptide Design and Optimization
Biomolecules
Designs new medicines from nature's building blocks.